How UM Ventures helped a biotech startup get acquired in 18 months - Technical.ly Baltimore

Sciences

Jul. 21, 2017 12:48 pm

How UM Ventures helped a biotech startup get acquired in 18 months

Living Pharma, which has technology to help develop a new form of cancer treatment, was acquired by Gaithersburg-based Lentigen Technology.

Living Pharma Inc.'s Board of Directors (L to R): Ron Dudek, Eduardo Davila and Phil Robilotto.

(Courtesy photo)

A startup that spun out of research at the University of Maryland School of Medicine was acquired 18 months after forming.

In a deal announced this week, Living Pharma was acquired by Lentigen Technology Inc., a Gaithersburg-based subsidiary of Miltenyi Biotec GmbH. Terms were not disclosed.

Living Pharma’s technology focuses on CAR T-cell therapy, an emerging form of treatment that uses re-engineered versions of a patient’s immune cells to target cancer cells. The technology, invented by UMSOM faculty member Eduardo Davila, is designed to regulate the treatment, and allow the treatment to target multiple kinds of cancer cells.

Biotech startups often take years to grow to the point of an exit. Along with the promise of the technology, UMB Assistant Vice President for Tech Transfer Phil Robilotto said Living Pharma’s acquisition was the result of a concerted effort by the university to provide resources.

The intellectual property was identified as ideal for a startup, and cofounder Ron Dudek joined the company to build the business. Along with the way, the team behind UM Ventures’ New Ventures Initiative including Mark Lafferty, Rana Quarishi and Darryl Carter handled a lot of the “legwork” involved in building the company, said Robilotto.

“Their role really is to help move these companies along and do a lot of the day to day work that is so important,” he said.

They’re also looking to increase the number of startups that form out of the university’s 150 invention disclosures a year.

With this deal, Dudek is relocating full-time to Maryland and joining Lentigen. The larger company provides more resources to help the technology advance, Robilotto said.

-30-
JOIN THE COMMUNITY, BECOME A MEMBER
Already a member? Sign in here
Connect with companies from the Technical.ly community
New call-to-action

Advertisement

Frederick-based RoosterBio raises $15M Series B

Biotech manufacturing center near BWI will have space to produce spinal muscular atrophy treatment

Genomics leader Illumina is opening a new center at University of Maryland BioPark

SPONSORED

Baltimore

Verizon is looking for the brightest ideas on how to use its 5G technology

Baltimore, MD 21201

14 West

Junior Database Administrator

Apply Now
Baltimore, MD

SmartLogic

Account Executive (Baltimore)

Apply Now
Baltimore, MD

14 West

Product Operations Manager

Apply Now

Ricoh brings bioprinting to new business with Baltimore biotechnology company

A trio of Baltimore institutions are forming partnerships with Baxter International

Johns Hopkins-founded startup developing blood test to detect cancer raises $110M

SPONSORED

Baltimore

Escape the August heat with cool AI tech

Philadelphia OR Baltimore

Technically Media

Technical.ly Editorial Intern (Fall 2019)

Apply Now
Baltimore

Fastspot

Business Development Manager

Apply Now
Columbia, MD

Vectorworks

Python Engineer (Software Systems Development)

Apply Now

Sign-up for daily news updates from Technical.ly Baltimore

Do NOT follow this link or you will be banned from the site!